San Francisco-based Alto Pharmacy raised $200 million in a late-stage funding round led by SoftBank Vision Fund, after reported talks of a merger with a blank-check firm backed by billionaire Alec Gores fell through late last year.
The company, which offers same-day delivery of prescription medicines, did not reveal its latest valuation, but was valued at more than $1 billion in early 2020 when it raised $250 million in a Series D funding round led by SoftBank, according to sources.
The company said on Thursday its revenue more than doubled in the past 12 months to over $700 million. It has also expanded its presence to 12 markets across the United States.
Read more: Reuters
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.